Real-World Mapping Antithrombotic Regimens in Multiple Myeloma Patients on Treatment (The MAMMOTH Study of the GIMEMA Working Party on Hemostasis and Thrombosis)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The goal of this observational study is to learn about antithrombotic regimens in Multiple myeloma patients. The main question it aims to answer is the efficacy of different types of thromboprophylaxis (antiplatelet agents, heparins, oral anticoagulants) in preventing venous thromboembolism (VTE).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age equal to or greater than 18 years of age.
• New diagnosis of symptomatic MM according to the CRAB or the SLIM criteria of the International Myeloma Working Group
• First active treatment for MM started after recruitment in the study
• Signed informed consent
Locations
Other Locations
Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS UOC Servizio e DH di Ematologia
RECRUITING
Roma
Contact Information
Primary
Paola Fazi
p.fazi@gimema.it
0670390528
Backup
Enrico Crea
e.crea@gimema.it
0670390514
Time Frame
Start Date: 2025-03-10
Estimated Completion Date: 2030-03
Participants
Target number of participants: 736
Related Therapeutic Areas
Sponsors
Leads: Gruppo Italiano Malattie EMatologiche dell'Adulto